+467.0%
MRNA vs VRSK
-32.3%
+499.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VRSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.2% | +5.2% | +5.3% |
| 7D | -1.1% | -5.2% | +4.1% | +2.4% |
| 30D | +126.1% | -2.3% | +128.4% | +131.5% |
| 3M | +190.0% | -2.9% | +193.0% | +194.1% |
| 6M | +157.2% | -12.8% | +170.0% | +168.6% |
| YTD | +388.2% | -20.8% | +409.0% | +427.9% |
| 1Y | +467.0% | -33.2% | +500.3% | +534.4% |
| All | +467.0% | -32.3% | +499.4% | +534.4% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSK.
Daily Out/Under-Performance
Portfolio return minus VRSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VRSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling